208 related articles for article (PubMed ID: 37283472)
21. Mutation Signatures Depend on Epigenomic Contexts.
Coleman N; De S
Trends Cancer; 2018 Oct; 4(10):659-661. PubMed ID: 30292349
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatic Methods to Identify Mutational Signatures in Cancer.
Islam SMA; Alexandrov LB
Methods Mol Biol; 2021; 2185():447-473. PubMed ID: 33165866
[TBL] [Abstract][Full Text] [Related]
23. Having a direct look: analysis of DNA damage and repair mechanisms by next generation sequencing.
Meier B; Gartner A
Exp Cell Res; 2014 Nov; 329(1):35-41. PubMed ID: 25131498
[TBL] [Abstract][Full Text] [Related]
24. Clinical and genomic characterization of mutational signatures across human cancers.
Liao J; Bai J; Pan T; Zou H; Gao Y; Guo J; Xu Q; Xu J; Li Y; Li X
Int J Cancer; 2023 Apr; 152(8):1613-1629. PubMed ID: 36533638
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA.
Wan JCM; Stephens D; Luo L; White JR; Stewart CM; Rousseau B; Tsui DWY; Diaz LA
Nat Commun; 2022 Aug; 13(1):4953. PubMed ID: 35999207
[TBL] [Abstract][Full Text] [Related]
26. Nuclear topology modulates the mutational landscapes of cancer genomes.
Smith KS; Liu LL; Ganesan S; Michor F; De S
Nat Struct Mol Biol; 2017 Nov; 24(11):1000-1006. PubMed ID: 28967881
[TBL] [Abstract][Full Text] [Related]
27. Deciphering signatures of mutational processes operative in human cancer.
Alexandrov LB; Nik-Zainal S; Wedge DC; Campbell PJ; Stratton MR
Cell Rep; 2013 Jan; 3(1):246-59. PubMed ID: 23318258
[TBL] [Abstract][Full Text] [Related]
28. Patterns and processes of somatic mutations in nine major cancers.
Jia P; Pao W; Zhao Z
BMC Med Genomics; 2014 Feb; 7():11. PubMed ID: 24552141
[TBL] [Abstract][Full Text] [Related]
29. The topography of mutational processes in breast cancer genomes.
Morganella S; Alexandrov LB; Glodzik D; Zou X; Davies H; Staaf J; Sieuwerts AM; Brinkman AB; Martin S; Ramakrishna M; Butler A; Kim HY; Borg Å; Sotiriou C; Futreal PA; Campbell PJ; Span PN; Van Laere S; Lakhani SR; Eyfjord JE; Thompson AM; Stunnenberg HG; van de Vijver MJ; Martens JW; Børresen-Dale AL; Richardson AL; Kong G; Thomas G; Sale J; Rada C; Stratton MR; Birney E; Nik-Zainal S
Nat Commun; 2016 May; 7():11383. PubMed ID: 27136393
[TBL] [Abstract][Full Text] [Related]
30. Mutational signature distribution varies with DNA replication timing and strand asymmetry.
Tomkova M; Tomek J; Kriaucionis S; Schuster-Böckler B
Genome Biol; 2018 Sep; 19(1):129. PubMed ID: 30201020
[TBL] [Abstract][Full Text] [Related]
31. Analysis of mutational signatures with yet another package for signature analysis.
Hübschmann D; Jopp-Saile L; Andresen C; Krämer S; Gu Z; Heilig CE; Kreutzfeldt S; Teleanu V; Fröhling S; Eils R; Schlesner M
Genes Chromosomes Cancer; 2021 May; 60(5):314-331. PubMed ID: 33222322
[TBL] [Abstract][Full Text] [Related]
32. Sequence dependencies and mutation rates of localized mutational processes in cancer.
Poulsgaard GA; Sørensen SG; Juul RI; Nielsen MM; Pedersen JS
Genome Med; 2023 Aug; 15(1):63. PubMed ID: 37592287
[TBL] [Abstract][Full Text] [Related]
33. Mutational signatures are markers of drug sensitivity of cancer cells.
Levatić J; Salvadores M; Fuster-Tormo F; Supek F
Nat Commun; 2022 May; 13(1):2926. PubMed ID: 35614096
[TBL] [Abstract][Full Text] [Related]
34. CANCERSIGN: a user-friendly and robust tool for identification and classification of mutational signatures and patterns in cancer genomes.
Bayati M; Rabiee HR; Mehrbod M; Vafaee F; Ebrahimi D; Forrest ARR; Alinejad-Rokny H
Sci Rep; 2020 Jan; 10(1):1286. PubMed ID: 31992766
[TBL] [Abstract][Full Text] [Related]
35. Unraveling the genomic landscape of colorectal cancer through mutational signatures.
Díaz-Gay M; Alexandrov LB
Adv Cancer Res; 2021; 151():385-424. PubMed ID: 34148618
[TBL] [Abstract][Full Text] [Related]
36. Regional mutational signature activities in cancer genomes.
Timmons C; Morris Q; Harrigan CF
PLoS Comput Biol; 2022 Dec; 18(12):e1010733. PubMed ID: 36469539
[TBL] [Abstract][Full Text] [Related]
37. The therapeutic significance of mutational signatures from DNA repair deficiency in cancer.
Ma J; Setton J; Lee NY; Riaz N; Powell SN
Nat Commun; 2018 Aug; 9(1):3292. PubMed ID: 30120226
[TBL] [Abstract][Full Text] [Related]
38. MutationalPatterns: the one stop shop for the analysis of mutational processes.
Manders F; Brandsma AM; de Kanter J; Verheul M; Oka R; van Roosmalen MJ; van der Roest B; van Hoeck A; Cuppen E; van Boxtel R
BMC Genomics; 2022 Feb; 23(1):134. PubMed ID: 35168570
[TBL] [Abstract][Full Text] [Related]
39. A framework for mutational signature analysis based on DNA shape parameters.
Karolak A; Levatić J; Supek F
PLoS One; 2022; 17(1):e0262495. PubMed ID: 35015788
[TBL] [Abstract][Full Text] [Related]
40. Decoding whole-genome mutational signatures in 37 human pan-cancers by denoising sparse autoencoder neural network.
Pei G; Hu R; Dai Y; Zhao Z; Jia P
Oncogene; 2020 Jul; 39(27):5031-5041. PubMed ID: 32528130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
